2-26898620-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PS1_ModeratePM2
The NM_020134.4(DPYSL5):c.121G>A(p.Glu41Lys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in UniProt.
Frequency
Genomes: not found (cov: 32)
Consequence
DPYSL5
NM_020134.4 missense
NM_020134.4 missense
Scores
1
9
9
Clinical Significance
Conservation
PhyloP100: 3.94
Genes affected
DPYSL5 (HGNC:20637): (dihydropyrimidinase like 5) This gene encodes a member of the CRMP (collapsing response mediator protein) family thought to be involved in neural development. Antibodies to the encoded protein were found in some patients with neurologic symptoms who had paraneoplastic syndrome. A pseudogene of this gene is found on chromosome 11. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PS1
Transcript NM_020134.4 (DPYSL5) is affected with MISSENSE_VARIANT having same AA change as one Pathogenic present in UniProt
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DPYSL5 | NM_020134.4 | c.121G>A | p.Glu41Lys | missense_variant | 2/13 | ENST00000288699.11 | NP_064519.2 | |
DPYSL5 | NM_001253723.2 | c.121G>A | p.Glu41Lys | missense_variant | 2/13 | NP_001240652.1 | ||
DPYSL5 | NM_001253724.2 | c.121G>A | p.Glu41Lys | missense_variant | 2/13 | NP_001240653.1 | ||
DPYSL5 | XM_024453007.2 | c.121G>A | p.Glu41Lys | missense_variant | 2/13 | XP_024308775.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Ritscher-Schinzel syndrome 4 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 22, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;T;T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;.;D;D;D
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;N;.;N;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;.;N
REVEL
Uncertain
Sift
Benign
T;T;T;T;.;T
Sift4G
Uncertain
T;T;T;D;T;D
Polyphen
0.012
.;B;B;.;B;.
Vest4
0.40, 0.40
MutPred
Gain of methylation at E41 (P = 0.0206);Gain of methylation at E41 (P = 0.0206);Gain of methylation at E41 (P = 0.0206);Gain of methylation at E41 (P = 0.0206);Gain of methylation at E41 (P = 0.0206);Gain of methylation at E41 (P = 0.0206);
MVP
MPC
1.1
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at